Since we first published “FDA Continues Proposed Extra-Statutory Authority Over Compounded Animal Drugs,” a number of impacted stakeholders have been expressing concern about the intended and unintentional consequences
Continue Reading Update to FDA’s Guidance #256 on Compounded Animal Drugs